The global AI in Energy Market was valued at USD 7.86 billion in 2026 and is projected to reach USD 26.46 billion by 2034, expanding at a CAGR of 16.4% during the forecast period. The market is experiencing rapid growth due to increasing digital transformation across the energy sector, rising investments in smart grids, growing adoption of renewable energy, and the need for intelligent energy...

The Clinical Trial Technology and Services Market is undergoing significant transformation as pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and healthcare research centers increasingly adopt digital technologies to improve clinical research. Clinical trials are essential for evaluating the safety and effectiveness of medicines, medical devices, and other...

Clinical trials are becoming increasingly complex, creating stronger demand for technologies capable of managing patient randomization, treatment allocation, drug supply, and operational coordination. Against this backdrop, the randomization and trial supply management (RTSM) market is gaining momentum as sponsors, contract research organizations (CROs), and other clinical research stakeholders...

Mechanical Thrombectomy Devices Market: Advancing Stroke Care Through Precision Neurointervention The mechanical thrombectomy devices market, commonly studied within the Neurothrombectomy Devices Market, is experiencing steady expansion due to the rising global burden of acute ischemic stroke and increasing adoption of minimally invasive neurointerventional procedures. Mechanical thrombectomy...

Market Overview The global Nicotinamide Adenine Dinucleotide (NAD) Market is experiencing strong growth, driven by increasing interest in cellular health, anti-aging research, metabolic disorders, and advanced therapeutic applications. NAD is a vital coenzyme found in all living cells, playing a crucial role in energy metabolism, DNA repair, and cellular signaling. It exists in two...

The Preclinical Imaging Market is becoming an increasingly important part of pharmaceutical research, biotechnology development, and translational medicine. Preclinical imaging technologies enable researchers to visualize and monitor biological processes, disease progression, treatment responses, and molecular activity in small-animal models. These technologies support drug discovery by...

The eClinical solutions market is becoming an increasingly important part of modern clinical research as pharmaceutical and biotechnology companies manage larger datasets, more complex protocols, decentralized trials, and stricter regulatory requirements. The market was valued at USD 11.5 billion in 2025 and is projected to grow from USD 13.1 billion in 2026 to USD 35.1 billion by 2033,...

The eClinical solutions market is becoming an increasingly important part of modern clinical research as pharmaceutical and biotechnology companies manage larger datasets, more complex protocols, decentralized trials, and stricter regulatory requirements. The market was valued at USD 11.5 billion in 2025 and is projected to grow from USD 13.1 billion in 2026 to USD 35.1 billion by 2033,...